This is the login page for PHARMA JAPAN WEB subscribers. PHARMA JAPAN WEB offers excerpts of some articles for free, but paid subscription is required to read full articles.

Today's Headlines RSS

REGULATORY

MHLW to Set Generic Share Target of 80% by FY2020-End: Shiozaki

The Ministry of Health, Labor and Welfare (MHLW) will set a new volume-based generic share target of 80% by the end of FY2020, while moving up the FY2017 deadline for ... > Read full story
ORGANIZATION
Generic Makers Need More Time to Meet Higher Target: JGA Leader (May.27)
REGULATORY
MHLW Approves MSD’s Pegintron for Adjuvant Therapy for Malignant Melanoma (May.27)
ORGANIZATION
3 Companies Received Guidance, 2 Received Warnings in FY2014 due to Fair Competition Code Violations: Maker’s FTC (May.27)
ORGANIZATION
JPMA Chief Fires at Proposed 80-90% Generic Share Target (May.27)
BUSINESS
Astellas’s New 3-Year Plan Targets Sales Growth in Mid-Single-Digit Range (May.27)
> More Latest News

Photosmore

  
Generic Makers Need More Time to Meet Higher Target: JGA Leader (May.27)JPMA Chief Fires at Proposed 80-90% Generic Share Target (May.27)Masanobu Suzuki Tapped as President of Nippon Kayaku (May.26)
  
Celgene Launches Multiple Myeloma Treatment Pomalyst; Keio Professor Acknowledges Its Efficacy in PFS, OS Improvement (May.26)Considerable Resolve Needed for Proposed 80% Generic Target: JGA (May.25)Blopress AG Share Tops 60% in Generic Market, Aims for Further Growth: ASKA President Yamaguchi (May.25)

News Categories

REGULATORY
   MHLW Approves MSD’s Pegintron for Adjuvant Therapy for Malignant Melanoma(May.27)
   MHLW to Set Generic Share Target of 80% by FY2020-End: Shiozaki(May.27)
   MHLW Notifies of Package Insert Change for Plavix(May.27)
BUSINESS
   Astellas’s New 3-Year Plan Targets Sales Growth in Mid-Single-Digit Range(May.27)
   GSK’s Aldreb Debuts as Last Resort for Multidrug Resistant Pseudomonas Aeruginosa Infection(May.26)
   Masanobu Suzuki Tapped as President of Nippon Kayaku(May.26)
ORGANIZATION
   Generic Makers Need More Time to Meet Higher Target: JGA Leader(May.27)
   3 Companies Received Guidance, 2 Received Warnings in FY2014 due to Fair Competition Code Violations: Maker’s FTC(May.27)
   JPMA Chief Fires at Proposed 80-90% Generic Share Target(May.27)
ACADEMIA
   MHLW-Funded Study Calls for Use-Based Development Plans for Combination Drugs(May.07)
   Six Deaths Confirmed through Tofacitinib PMS, Guidelines Not Followed in All Cases(Apr.30)
   Biometric Society of Japan to Establish Certification System for Biostatisticians(Apr.17)

Commentary

Thorny Path Ahead toward Trial Rollout of Cost-Effective Assessment in FY2016; Chuikyo to Begin Discussions on May 27

Lexicon

Japan Agency for Medical Research and Development (AMED):
日本医療研究開発機構

The Column

“Every Search Is Won Before It’s Ever Fought”: Sun Tzu

Archives

MHLW Notifies of Package Insert Change for Plavix(May.27)
ICH Likely to OK Brazil, China as Assembly Members at Fukuoka Confab(May.26)
GSK’s Aldreb Debuts as Last Resort for Multidrug Resistant Pseudomonas Aeruginosa Infection(May.26)
Masanobu Suzuki Tapped as President of Nippon Kayaku(May.26)
MHLW Grants Orphan Designation for Rituximab, Metirosine(May.26)

Most Read

1.
Japan’s Biosimilar Market to Rise to 31....
2.
Sales of SGLT-2 Inhibitors Were Sluggish...
3.
Top-4 Japanese Drug Makers Report Widely...
4.
Daiichi Sankyo, Takeda to Join in Distri...
5.
Panel OKs Sovaldi for Medical Subsidy, M...

News Calendar